Learn About STELARA® (ustekinumab) for Ulcerative Colitis | STELARA . . . Two of these proteins, interleukin 12 (IL-12) and interleukin 23 (IL-23), have been implicated as important contributors to the chronic inflammation that is a main feature of ulcerative colitis STELARA ® is the only FDA-approved medication that targets these two proteins
Ulcerative Colitis: Patient Resources - STELARA® (ustekinumab) Find patient resources for STELARA®, including cost, injection, and other support information for your treatment of ulcerative colitis See full Prescribing Safety Information including Crohn’s disease and ulcerative colitis As of March 2023, it has been passed into law in 20 states and the District of Columbia Included here is a
STELARA withMe: Personalized Support For Your Ulcerative Colitis (UC . . . STELARA ® is not for everyone; only your doctor can decide if it's right for you STELARA ® is a prescription medicine that affects your immune system It can increase your chance of having serious side effects including serious infections, cancer, serious allergic reactions, lung inflammation, and a rare condition called posterior reversible
HIGHLIGHTS OF PRESCRIBING INFORMATION STELARA (ustekinumab) These . . . STELARA® is indicated for the treatment of patients 6 years or older with active psoriatic arthritis 1 3 Crohn’s Disease (CD) STELARA® is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease 1 4 Ulcerative Colitis STELARA® is indicated for the treatment of adult patients with moderately to
Conoce Stelara para la Colitis Ulcerosa | STELARA® (ustekinumab) stelara ® es el primer medicamento aprobado para la colitis ulcerosa en reducir la inflamaciÓn sobre y bajo la superficie del intestino Reducción de la inflamación observada bajo el microscopio y durante la colonoscopia en el 17% de los pacientes a las 8 semanas y en el 44% de los pacientes tras 1 año
Ulcerative Colitis: Cost Support Options for STELARA® | STELARA . . . The list price of STELARA ® is $25,497 12 every 8 weeks for the 90 mg dose as of March 2022 * Eligible commercial patients can save with the STELARA withMe Savings Program List price does not reflect a patient’s out-of-pocket cost and does not include samples, vouchers, the cost of administering the medication, or pharmacy fees
STELARA® (ustekinumab) for Crohns Disease | STELARA® (ustekinumab) STELARA ® is not for everyone; only your doctor can decide if it's right for you STELARA ® is a prescription medicine that affects your immune system It can increase your chance of having serious side effects including serious infections, cancer, serious allergic reactions, lung inflammation, and a rare condition called posterior reversible encephalopathy syndrome
FOR ADULTS WITH MODERATELY TO SEVERELY ACTIVE CROHNS DISEASE (CD) OR . . . 1 YEAR WITH STELARA® PLEASE SEE SUPPORTING DATA WITHIN FOR ADULTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE (CD) OR ULCERATIVE COLITIS (UC) LASTING REMISSION CD UC STELARA® is a prescription medicine used to treat adults 18 years and older with moderately to severely active Crohn’s disease or ulcerative colitis